Your browser doesn't support javascript.
loading
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
Cullum, Richard L; Lucas, Lauren M; Senfeld, Jared I; Piazza, John T; Neel, Logan T; Whig, Kanupriya; Zhai, Ling; Harris, Mackenzie H; Rael, Cristina C; Taylor, Darby C; Cook, Laura J; Kaufmann, David P; Mill, Christopher P; Jacobi, Megan A; Smith, Forrest T; Suto, Mark; Bostwick, Robert; Gupta, Ram B; David, Allan E; Riese Ii, David J.
Afiliación
  • Cullum RL; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Lucas LM; Department of Chemical Engineering, Auburn University, Auburn, AL, United States of America.
  • Senfeld JI; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Piazza JT; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Neel LT; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Whig K; Department of Biological Sciences, Auburn University, Auburn, AL, United States of America.
  • Zhai L; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Harris MH; Drug Discovery Division, Southern Research, Birmingham, AL, United States of America.
  • Rael CC; Drug Discovery Division, Southern Research, Birmingham, AL, United States of America.
  • Taylor DC; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Cook LJ; Department of Chemical Engineering, Auburn University, Auburn, AL, United States of America.
  • Kaufmann DP; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Mill CP; Department of Biological Sciences, Auburn University, Auburn, AL, United States of America.
  • Jacobi MA; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Smith FT; Department of Biological Sciences, Auburn University, Auburn, AL, United States of America.
  • Suto M; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Bostwick R; Department of Chemistry and Biochemistry, Auburn University, Auburn, AL, United States of America.
  • Gupta RB; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • David AE; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Riese Ii DJ; Department of Leukemia, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
PLoS One ; 15(12): e0243901, 2020.
Article en En | MEDLINE | ID: mdl-33378376
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proliferación Celular / Receptor ErbB-4 / Melanoma / Factores de Crecimiento Nervioso Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proliferación Celular / Receptor ErbB-4 / Melanoma / Factores de Crecimiento Nervioso Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos